Article
Genetic microevolution of clinical Candida auris with reduced Amphotericin B sensitivity in China.
Emerging microbes & infections - 1 Dec 2024
Tian Sufei, Rong Chen, Li Hailong, Wu Yusheng, Wu Na, Chu Yunzhuo, Jiang Ning, Zhang Jingping, Shang Hong
Abstract excerpt
The global rate of Amphotericin B (AmB) resistance in Candida auris has surpassed 12%. However, there is limited data on available clinical treatments and microevolutionary analyses concerning reduced AmB sensitivity. In this study, we collected 18 C. auris isolates from five patients between 2019 and 2022. We employed clinical data mining, genomic, and transcriptomic analyses to identify genetic evolutionary...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
